140 related articles for article (PubMed ID: 31832521)
1. Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma.
Tang J; Zhang L; Zhou T; Sun Z; Kong L; Jing L; Xing H; Wu H; Liu Y; Zhou S; Li J; Chen M; Xu F; Tang J; Ma T; Hu M; Liu D; Guo J; Zhu X; Chen Y; Ye T; Wang J; Li X; Xing HR
Genes Dis; 2019 Dec; 6(4):407-418. PubMed ID: 31832521
[TBL] [Abstract][Full Text] [Related]
2. [Biological Characteristics of Immunophenotype, Stem Cell Gene and Colony Forming Ability in Side-Population Cells of Jeko-1 Cell Line].
Zhou SX; Zhang L; Li XM; Tang JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1558-1562. PubMed ID: 33067954
[TBL] [Abstract][Full Text] [Related]
3. Prospective isolation of clonogenic mantle cell lymphoma-initiating cells.
Chen Z; Ayala P; Wang M; Fayad L; Katz RL; Romaguera J; Caraway N; Neelapu SS; Kwak LW; Simmons PJ; McCarty N
Stem Cell Res; 2010 Nov; 5(3):212-25. PubMed ID: 20851072
[TBL] [Abstract][Full Text] [Related]
4. Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma.
Jung HJ; Chen Z; McCarty N
Leuk Lymphoma; 2011 Jun; 52(6):1066-79. PubMed ID: 21599592
[TBL] [Abstract][Full Text] [Related]
5. Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.
Knapp CM; He J; Lister J; Whitehead KA
Exp Biol Med (Maywood); 2016 May; 241(9):1007-13. PubMed ID: 27022142
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic and genetic characterization of a CD8 positive mantle cell lymphoma in a patient with concomitant Mycosis fungoides.
Schroers R; Hildebrandt Y; Steffens R; Becker S; Ohms G; von Bonin F; Haase D; Bertsch HP; Trümper L; Griesinger F
Eur J Haematol; 2005 Jul; 75(1):78-84. PubMed ID: 15946316
[TBL] [Abstract][Full Text] [Related]
7. Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells.
Medina DJ; Abass-Shereef J; Walton K; Goodell L; Aviv H; Strair RK; Budak-Alpdogan T
PLoS One; 2014; 9(4):e91042. PubMed ID: 24722054
[TBL] [Abstract][Full Text] [Related]
8. Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy.
Yang C; Lei W; Xie H; Wu G; Wei J; Liang A; Qian W
Onco Targets Ther; 2020; 13():12163-12168. PubMed ID: 33268994
[TBL] [Abstract][Full Text] [Related]
9. Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphoma.
Liu Z; Liu J; Zhang T; Li L; Zhang S; Jia H; Xia Y; Shi M; Zhang J; Yue S; Chen X; Yu J
BMC Cancer; 2021 Jun; 21(1):732. PubMed ID: 34174847
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing Screen Identifies Novel Classes of Drugs with Anticancer Activity in Mantle Cell Lymphoma.
Han C; Yu X; Zhang C; Cai Y; Cao Y; Wang S; Shen J
Comb Chem High Throughput Screen; 2019; 22(7):483-495. PubMed ID: 31526347
[TBL] [Abstract][Full Text] [Related]
11. P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines.
Shirsath NP; Manohar SM; Joshi KS
Mol Cancer; 2012 Oct; 11():77. PubMed ID: 23075291
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 4 mantle cell lymphoma cell lines.
Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma.
Jung HJ; Chen Z; Fayad L; Wang M; Romaguera J; Kwak LW; McCarty N
Exp Hematol; 2012 Feb; 40(2):107-18.e2. PubMed ID: 22024108
[TBL] [Abstract][Full Text] [Related]
14. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract][Full Text] [Related]
16. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
17. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.
Zoldan MC; Inghirami G; Masuda Y; Vandekerckhove F; Raphael B; Amorosi E; Hymes K; Frizzera G
Br J Haematol; 1996 May; 93(2):475-86. PubMed ID: 8639452
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a mantle cell lymphoma cell line.
Jeon HJ; Kim CW; Yoshino T; Akagi T
Br J Haematol; 1998 Sep; 102(5):1323-6. PubMed ID: 9753063
[TBL] [Abstract][Full Text] [Related]
19. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
20. Expression and role of MIG/CXCR3 axis in mantle cell lymphoma.
Zhu MX; Wan WL; Hong Y; Wang YF; Dong F; Jing HM
Exp Cell Res; 2020 Dec; 397(2):112365. PubMed ID: 33197439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
